Smart Pain Assesment Tool Based on Internet of Things (SPA)

December 21, 2018 updated by: Sanna Salanterä, University of Turku
This study is the second phase of a research project called "Smart Pain Assessment Tool based on Internet-of-Things". During the course of this project, a smart pain assessment tool (SPA) to detect and assess pain employing behavioural and physiologic indicators will be developed. We aim to assess pain based on changes in electromyographic (EMG) activity in facial muscles, i.e. changes in facial expressions and simultaneously use physiologic signs such as heart rate, respiratory rate and galvanic skin response as adjuvant measures to develop an algorithm for pain assessment in critically ill patients.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The aim of this "smart pain assessment tool based on internet of things" SPA-research project is to develop an automatic and versatile pain assessment tool algorithm for detection and assessment of pain in a reliable and objective way in non-communicative patients. The final objective of the research project is to develop a smart pain assessment tool to detect and assess pain employing behavioural and physiologic indicators for a wide range of users/patients from infants to elderly people who are unable to communicate normally. The research project consists of three clinical phases (European Commision. Meddev 2.7/4/2010). The clinical phase I of the research project focused on developing pain assessment techniques involuntary working-age healthy study subjects. This current Clinical phase II includes the further development and research of the smart pain assessment tool in elective (non emergency) postoperative surgical patients during their stay after surgery in a recovery room.

Study Type

Interventional

Enrollment (Actual)

58

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Turku, Finland, 20140
        • University of Turku

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Subject is scheduled for major surgery that requires general anesthesia and is likely to cause moderate to severe pain postoperatively which needs to be treated with systemic analgesics
  • Ability to communicate
  • Written informed consent
  • Healthy facial skin

Exclusion Criteria:

  • Subject treated with local anesthesia during surgery
  • Any diagnosed condition affecting cognitive functions
  • Surgery affecting hands where pulse oximetry and galvanic skin reaction are recorded or areas where facial muscle activity is measured
  • Any diagnosed condition affecting central nervous system, facial nerves or muscles.
  • Significant facial hair growth in the area where the sensors will be attached
  • Tattoos in the area where the sensors will be attached

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Postoperative patients
We recruit postoperative patients who undergo open surgery and are not receiving local anesthesia. We install a smart pain assessment tool on patient's skin to capture different type of data.
We record and analyze multiple bio-signals from post-operative patients in the attempt to evaluate their experienced pain.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Facial muscle activity
Time Frame: 2 hours after surgery when the subject has woken up
The device is designed for multi-channel EMG acquisition from facial skin. Measuring a combination of EMG signals and their energy level (amplitude).
2 hours after surgery when the subject has woken up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Skin conductance
Time Frame: 2 hours after surgery when the subject has woken up
Galvanic skin response (GSR), also known as electrodermal activity (EDA) or skin conductance (SC).
2 hours after surgery when the subject has woken up
Pain assesment by VAS
Time Frame: 2 hours after surgery when the subject has woken up
Subjective feeling of pain is asked every 10 minutes by using numeric visual analog scale (VAS), values are given from 0-10.
2 hours after surgery when the subject has woken up
Heart rate
Time Frame: 2 hours after surgery when the subject has woken up
Heart rate is monitored and recorded.
2 hours after surgery when the subject has woken up
Respiratory rate
Time Frame: 2 hours after surgery when the subject has woken up
Respiratory rate is monitored and recorded.
2 hours after surgery when the subject has woken up
Oxygen saturation
Time Frame: 2 hours after surgery when the subject has woken up
Oxygen saturation is monitored and recorded.
2 hours after surgery when the subject has woken up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Sanna Salanterä, Prof, University of Turku

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 20, 2017

Primary Completion (Actual)

June 11, 2018

Study Completion (Actual)

June 11, 2018

Study Registration Dates

First Submitted

February 9, 2017

First Submitted That Met QC Criteria

February 17, 2017

First Posted (Actual)

February 23, 2017

Study Record Updates

Last Update Posted (Actual)

December 24, 2018

Last Update Submitted That Met QC Criteria

December 21, 2018

Last Verified

December 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • 29092016

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain

Clinical Trials on Smart pain assessment tool

3
Subscribe